GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam

Submit press release

Existing customer?
Log in

New customer?
Sign up

Latest Headlines
How Cisco Foundation and Social Impact Investments Are Driving Impact at...
BONUS: Best-In-Class Landfill Design: A Case...
6 Questions for 6 Billion Square Feet: A Conversation With IWBI's...
Net Impact Announces Global Case Competition on Social Impact and Business...
The Power of Water: How the Angola Institutional and Sustainability...
The Economic Community of West African States (ECOWAS) Commission experts...

M2 Archive: Preview

You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.

GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam

GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam
YONGIN, South Korea, July 17, 2025 - GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from the Drug Administration of...

If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search